Company Description
Inflazyme Pharmaceuticals flamed out on its research into respiratory disease. The firm had been developing treatments for respiratory diseases...
Key Inflazyme Financials
| Company Type | Public - Canadian NEX: IZP Main Headquarters |
|---|---|
| Fiscal Year-End | March |
| 2005 Employees | 30 |
More Inflazyme Financials (1 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Inflazyme's competition across multiple industries
Sponsored Links
The Business DirectoryTrading Toolbox
Inflazyme Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Jeremy Curnock Cook | Network | E-mail |
| President, Acting CEO, and Director | Michael Liggett | Network | E-mail |
| Senior Director Corporate Development | Julie Rezler | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Inflazyme News
- BioWorld Today June 16, 2008 [BioWorld Today] (16 Jun 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.







